Table 3.
The number of participants within each region and overall who stated their organizations had pre-transfer medical requirements (percentages in parentheses).
| Procedure | Midwest | Northeast | South | West | Total |
|---|---|---|---|---|---|
| Rabies Vaccine | 28/52 (53.8%) | 55/78 (70.5%) | 13/30 (43.3%) | 15/33 (45.5%) | 111 (57.5%) |
| Distemper/Parvovirus Vaccine | 20/52 (38.5%) | 54/78 (69.2%) | 13/30 (43.3%) | 17/33 (51.5%) | 104 (53.9%) |
| Heartworm Test, Treatment, and/or Preventative | 11/52 (21.2%) | 38/78 (48.7%) | 9/30 (30.0%) | 10/33 (30.3%) | 68 (35.2%) |
| Bordetella Vaccine | 11/52 (21.2%) | 23/78 (29.5%) | 9/30 (30.0%) | 8/33 (24.2%) | 51 (26.4%) |
| Fecal Testing/Deworming | 9/52 (17.3%) | 25/78 (32.1%) | 6/30 (20.0%) | 6/33 (18.2%) | 46 (23.8%) |
| Spay/Neuter | 6/52 (11.5%) | 24/78 (30.8%) | 8/30 (26.7%) | 5/33 (15.2%) | 43 (22.3%) |
| Testing and/or Treatment for External Parasites | 6/52 (11.5%) | 15/78 (19.2%) | 2/30 (6.7%) | 5/33 (15.2%) | 28 (14.5%) |
| Testing and/or Treatment for Tick-Borne Illnesses | 0/52 (0.0%) | 9/78 (11.5%) | 2/30 (6.7%) | 0/33 (0.0%) | 11 (5.7%) |
| Microchip | 0/52 (0.0%) | 6/78 (7.7%) | 2/30 (6.7%) | 1/33 (3.0%) | 9 (4.7%) |